Activation of LYN kinase is associated with imatinib-resistance in CML patients
Wednesday, June 25, 2008 - 02:56
in Health & Medicine
Activation of LYN kinase is associated with resistance to imatinib (Gleevec) in patients with chronic myelogenous leukemia (CML), researchers report in the June 24 online issue of the Journal of the National Cancer Institute.